Published:
Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)
SWARTZ CREEK, Mich., Oct. 10 /PRNewswire/ -- Diplomat Specialty Pharmacy
announced today that Teva Neuroscience has selected Diplomat Specialty
Pharmacy to be one of only three sites to participate in a large scale,
national Therapy Optimization Study for Multiple Sclerosis (TOP MS).
The goal, of the two year TOP MS study, is to examine the benefits of a
specialty pharmacy therapy management program on compliance, adherence and
patient outcomes. Targeted patient outcomes will include: Relapses,
Disability Progression, Quality of Life, and Work and Usual Activity
Participation.
"We are honored that Teva Neuroscience selected Diplomat to participate in
this study," said Phil Hagerman, President and CEO of Diplomat. "I have no
doubt that the TOP MS study will validate the benefits of our patient centric
model. When we focus on adherence and tolerance, and offer patients a
personalized medication program, we can reduce the frequency and severity of
relapses and ultimately improve the quality of life."
"Diplomat Specialty Pharmacy was selected to participate in this study
because they have shown a commitment to therapy management in MS that is
exemplary among Specialty Pharmacies," said MerriKay Oleen-Burkey, Project
Leader for the TOP MS Study at Teva Neuroscience.
"This really is a credit to Diplomat's industry leading MS Navigator
program that currently benefits physicians and especially MS patients across
the country," said Ken Visser, Diplomat's National Accounts Manager for
Multiple Sclerosis. "At Diplomat we maximize therapy adherence by enhancing
patient education and prescriber communication. Using our exclusive eNAV(TM)
patient care software system, we can electronically record and report our
patients' therapy and disease. All of this combined amounts to some of the
highest patient adherence numbers in the country."
About Diplomat Specialty Pharmacy
Diplomat Specialty Pharmacy is the nation's largest independently held
Specialty Pharmacy and focuses on complete medication management programs for
patients with serious and chronic conditions. Key programs include:
Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis,
Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility,
Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and
Specialty Compounding. The company also specializes in Disease Management
programs for Chronic Kidney Disease patients, as well as Home and Out-Patient
Infusion. With locations inFlint,Swartz Creek andGrand Rapids, MI;
Cleveland, OH;Chicago, IL; andFt. Lauderdale, Florida; Diplomat services the
specialty pharmacy needs of patients and physicians nationwide.
About Teva Neuroscience
Teva Neuroscience is the branded neurological products franchise of Teva
Pharmaceutical Industries Ltd. and is responsible for the development,
registration and marketing for Teva's branded neurological products inNorth
America. Teva Neuroscience has administrative, commercial marketing, and other
leadership functions based inKansas City, MO at its North American
headquarters, as well as a facility inHorsham, PA, home to the company's
clinical research activities and regulatory functions, and an office in
Montreal, Quebec, headquarters for the company's Canadian presence.
Contact: Ken Visser, National Accounts Manager for Multiple Sclerosis
Phone: 616-242-1082
Fax: 616-454-9095
Email: kvisser@diplomatpharmacy.com
SOURCE Diplomat Specialty Pharmacy
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily News
Tags: ,MTC,HEA,STW,NET,CPR,TRI,SVY,JVN,MI-Diplomat-Teva-stdy
_ _Is your favorite bookmark site missing?
Ask for it.